Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2010
06/02/2010CN101229179B Use of oil orange phlorizin-B in preparing medicine
06/02/2010CN101229158B Medicine compounds for treating tumour and applications thereof
06/02/2010CN101229131B Novel type nanometer particle preparation capable of reducing gastroenteritic toxicity of camptothecin medicines
06/02/2010CN101229121B Penciclovir microemulsion gel preparation and preparing method thereof
06/02/2010CN101224215B Uses of ursolic acid saponin and oleanolic acid saponin in preparing medicine for increasing white blood cell and/or blood platelet
06/02/2010CN101220044B Telomerase inhibitor, preparation method and application thereof
06/02/2010CN101219130B Compound pharmaceutical composition, preparation method and use of the same
06/02/2010CN101219114B Pennogenin compounds solid state molecule dispersion preparation
06/02/2010CN101210022B Cephalosporin
06/02/2010CN101209354B Medical blood-stopping healing agent for wound-surface and uses thereof
06/02/2010CN101209338B Chinese medicine for treating cutaneous hemangioma
06/02/2010CN101199540B Polygonin sheet and preparing method thereof
06/02/2010CN101199510B Silybin precursor multiphase lipidosome formulation and preparing method thereof
06/02/2010CN101190922B Cephalosporin derivative
06/02/2010CN101190310B Traditional Chinese medicine composition for treating mazopathy
06/02/2010CN101182332B Manganese complexes having antitumor and affecting mitochondria functions and its preparation method
06/02/2010CN101181578B Rose strip containing natural aromatic plant
06/02/2010CN101181577B Lavender strip containing natural aromatic plant
06/02/2010CN101181574B Chinese vetch strip containing natural aromatic plant
06/02/2010CN101181495B Prescription with ringing function and uses thereof
06/02/2010CN101181420B Chinese medicine composition externally used for curing tinea unguium
06/02/2010CN101181288B Solid-state molecule disperse preparations of pennogenin series compounds
06/02/2010CN101181260B Rabdosia nail element clathrate and pharmaceutical preparation containing the same
06/02/2010CN101181253B Chloromycetin eyedrops with long shelf-life and preparation method thereof
06/02/2010CN101181252B Chloromycetin eyedrops with long shelf-life and preparation method thereof
06/02/2010CN101172111B Application of sterides in preparing medicament for treating cardiovascular and cerebrovascular diseases
06/02/2010CN101167820B External-applied traditional Chinese medicine for curing uterus cancer and its preparation method
06/02/2010CN101157684B Aspartic acid lomefloxacin hydrate and preparation and uses thereof
06/02/2010CN101153045B Novel cephalosporin compounds
06/02/2010CN101152197B Compound glycyrrhizin dropping pills and method for preparing the same
06/02/2010CN101152171B Method of preparing mildronate injection
06/02/2010CN101148437B Biinomenine derivative connected with C-C bond, preparation method and application thereof
06/02/2010CN101139350B Oridonin derivative, preparation method and uses thereof
06/02/2010CN101129437B Medicine for treating pile and method of preparing the same
06/02/2010CN101125136B Application of alpinia officinarum hance diarylheptanes compound in pain-alleviating and anti-inflammatory and its extracting method
06/02/2010CN101120928B Vitamin K1 orally disintegrating tablets preparation and preparation method thereof
06/02/2010CN101116662B Application of sophocarpine in the preparation of medicine for treating adenovirus-caused inflammation
06/02/2010CN101112484B Burns and scalds treating medicine and production process thereof
06/02/2010CN101108869B Mangiferin salt and method of preparing the same and use thereof
06/02/2010CN101091767B Plaster of anti-inflammation, dissolving lumps, and ease pain, and preparation method
06/02/2010CN101066298B Chinese medicine powder for treating portacaval mucositis
06/02/2010CN101054345B Novel bensophenone derivatives or salts thereof
06/02/2010CN101053592B Medicinal composition for treating impaired glucose tolerance and preparation method thereof
06/02/2010CN101053583B Method for preparing chrysanthemum Ieucanthemum granules
06/02/2010CN101036714B Medicinal composition for treating and/or preventing diabetes
06/02/2010CN101035761B 3,6-substituted 5-arylamino-1h-pyridine-2-one derivatives and related compounds as poly(ADP-ribose) polymerase(PARP) inhibitors in the treatment of tissue damage or diseage caused by necrosis or apopt
06/02/2010CN101028319B Chinese-medicine compound preparation against coronary heart disease and its production
06/02/2010CN101007771B Voglibose semi-hydrated crystal, its preparation method and its uses in medicament formulation
06/02/2010CN101002786B Plaster for treating hepatitis B, and its preparing method
06/01/2010US7729738 Stabilized tissue penetrating catheters
06/01/2010US7728188 Methods and compositions for topical wound treatment
06/01/2010US7728169 Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use
06/01/2010US7728158 PPAR activity regulators
06/01/2010US7728153 anticancer agents; angiogenesis inhibitors; fatty acid synthase inhibitors
06/01/2010US7728146 dipeptidyl peptidase IV inhibitors, capable of crossing the blood-brain-barrier in mammals, useful for the treatment of neurological and neurodegenerative diseases, such as anxiety, depression and Alzheimer's disease
06/01/2010US7728144 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; biphenyl carbamic acid, piperidinyl ester derivatives
06/01/2010US7728141 Substituted naphthyridinone derivatives
06/01/2010US7728135 such as 4-[4-[(R)-[1-[cyclopropylsulfonyl)-4-piperidinyl](3-fluorophenyl)methyl]-3(S)-methyl-1-piperazinyl]-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]-4-methylpiperidine; chemokine receptors (CCR5)
06/01/2010US7728134 Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
06/01/2010US7728133 Stable pharmaceutical compositions
06/01/2010US7728131 Amide derivative and medicine
06/01/2010US7728127 Cross-linked glycopeptide-cephalosporin antibiotics
06/01/2010US7728125 Modified maltodextrin and/or syrup solid comprising superior colorfastness and thermal stability
06/01/2010US7728043 Administering to a subject suffering from the beta-Amyloid protein-induced cytotoxicity, ketone compounds isolated from turmeric, gingko biloba, and ginger, and synthetic chemical analogues
06/01/2010US7728042 Transdermal pharmaceutical composition
06/01/2010US7728041 such as N-(3-Amino-propyl)-N'-anthracen-9-ylmethyl-N'-ethyl-propane-1,3-diamine, having cytotoxic activity to cancer cells; antimetastatic agents
06/01/2010US7728040 Polyamine conjugates as selective NMDA inhibitors and anti-cancer drugs
06/01/2010US7728039 such as E-3-(4'-hydroxy-biphenyl-4-yl)-N-hydroxy-acrylamide, useful for the treatment of drug-resistant tumors
06/01/2010US7728038 administering 1-N-docosyltriethylenetetraminepentaacetic acid, as an iron chelator, vitamin E, estrogen and/or mixtures thereof, optionally linked to nanoparticles, for the treatment of bone disorders
06/01/2010US7728037 Alpha-ketoglutarates of active ingredients and compositions containing same
06/01/2010US7728036 Methods for delivery of catecholic butanes for treatment of tumors
06/01/2010US7728035 Ester derivatives of rhein and their therapeutic use
06/01/2010US7728034 Treating neurological disorders using selective antagonists of persistent sodium current
06/01/2010US7728033 Mycophenolate mofetil in diabetic nephropathy
06/01/2010US7728031 Octahydro-pyrrolo[3,4-b]pyrrole derivatives
06/01/2010US7728030 novel indazolyl ester or amide derivatives; N-((1S,2R)-2-{[1-(4-fluorophenyl)-1H-indazol-5-yl]oxy}-1-methyl-2-phenylethyl)cyclopropanecarboxamide; non-steroidal compounds as modulators of the glucocorticoid receptor; acylation
06/01/2010US7728029 hydroxysteroid reductase inhibitors such as 2'-tert-butyl-2'H-[1,3']bipyrazolyl-4'-carboxylic acid (5-hydroxy-adamantan-2-yl)-amide, used for the treatment of non-insulin dependent diabetes mellitus and metabolic syndrome
06/01/2010US7728028 Substituted imidazoline compounds
06/01/2010US7728027 reacting 2-bromo-1-[4-[4-(2-bromoacetyl)phenyl]phenyl]ethanone with 1-(tert-butoxycarbonyl)-L-proline, then treating the product with ammonium acetate and deprotection to form chemical intermediates for viricides; cost efficiency; industrial scale
06/01/2010US7728026 2-substituted-1 h-benzimidazile-4-carboxamides are PARP inhibitors
06/01/2010US7728025 Glucokinase activators as antidiabetic, antiobesity agents; 5-(4-methanesulfonyl-phenoxy)-2-pyrazin-2-yl-6-(2-carbamoyl-phenoxy)-1H-benzimidazole for example
06/01/2010US7728024 Metal salts of 2′-(1H-Tetrazol-5yl)-1.1′-biphenyl-4-carboxaldehyde
06/01/2010US7728023 Respiratory system disorders; leukotriene receptor antagonists; asthma, chronic obstructive pulmonary disease, pulmonary emphysema, chronic bronchitis, pneumonia; 1-(3-carboxypropyl)-4-{(E)-2-[4-(4-phenylbutoxy)phenyl]vinyl}-1H-indole-3-carboxylic acid
06/01/2010US7728022 (4, 5, 6, 7-tetrahydro-1-H-indol-7-yl) acetic acid derivatives for treatment of Alzheimer's disease
06/01/2010US7728021 Process for the preparation of Valsartan and precursors thereof
06/01/2010US7728020 such as 3-amino-5-(4-heptyloxy-phenyl)-3-methyl-pentanoic acid, useful in the treatment and/or prevention of diseases or disorders mediated by lymphocytes interactions e.g. in transplant rejection and autoimmune diseases
06/01/2010US7728018 Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-HT6 antagonists
06/01/2010US7728017 1,2,4-triazolo[3,4-b][1,3,4]thiadiazole derivatives, useful as tyrosine kinase inhibitors for treating or lessening the severity of proliferative disorders
06/01/2010US7728016 Substituted 5-membered ring compounds and their use
06/01/2010US7728015 Compositions for weight management
06/01/2010US7728014 Heteroaromatic compounds having sphingosine-1-phosphate (S1P) receptor agonist biological activity
06/01/2010US7728013 derivatives of pirfenidone which can modulate a stress activated protein kinase (SAPK) system; treatment of various inflammatory conditions and/or fibrotic conditions such as inflammatory pulmonary fibrosis and/or idiopathic pulmonary fibrosis
06/01/2010US7728012 N-(3-Amino-1-benzyl-2,3-dioxopropyl)-2-{3-[3-(trifluoromethyl)phenyl]-1H-pyrazol-1-yl}nicotinamide; neurodegenerative disorders, chronic brain supply deficit, ischemia (stroke) o brain trauma, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease
06/01/2010US7728011 Dermally applicable liquid formulations for controlling parasitic insects on animals
06/01/2010US7728010 Substituted benz-azoles and methods of their use as inhibitors of Raf kinase
06/01/2010US7728009 such as 1-{[2-(2,3-dimethylphenyl)-4- methyl-1,3-thiazol-5-yl]carbonyl}- 4-isopropylpiperazine, used to modulate ligand binding to histamine H3 receptors in vivo or in vitro, and particularly useful in the treatment of central nervous system disorders in humans
06/01/2010US7728008 N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
06/01/2010US7728007 Therapeutic amides
06/01/2010US7728006 Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
06/01/2010US7728005 such as N-(2-bromophenyl)-N'-[2-(4-fluorophenoxy)ethyl]urea, having superior antiinflammatory and analgesic activity
1 ... 2246 2247 2248 2249 2250 2251 2252 2253 2254 2255 2256 2257 2258 2259 2260 2261 2262 2263 2264 2265 2266 ... 7860